|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Babjuk M, Bohle A, Burger M, Capoun O,
Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M,
et al: EAU guidelines on non-muscle-invasive urothelial carcinoma
of the bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar
|
|
3
|
Anastasiadis A and de Reijke TM: Best
practice in the treatment of nonmuscle invasive bladder cancer.
Ther Adv Urol. 4:13–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shah JB, McConkey DJ and Dinney CP: New
strategies in muscle-invasive bladder cancer: On the road to
personalized medicine. Clin Cancer Res. 17:2608–2612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adelman K and Egan E: Non-coding RNA: More
uses for genomic junk. Nature. 543:183–185. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang F, Qi W, Wang Y, Wang W and Fan L:
lncRNA PEG10 promotes cell survival, invasion and migration by
sponging miR-134 in human bladder cancer. Biomed Pharmacother.
114:1088142019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seitz AK, Christensen LL, Christensen E,
Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM,
Palmfeldt J, Thomson M, et al: Profiling of long non-coding RNAs
identifies LINC00958 and LINC01296 as candidate oncogenes in
bladder cancer. Sci Rep. 7:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng SQ, Zhang XY, Fan HT, Sun QJ and
Zhang M: Up-regulation of LncRNA MEG3 inhibits cell migration and
invasion and enhances cisplatin chemosensitivity in bladder cancer
cells. Neoplasma. 65:925–932. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W
and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine
resistance through CREB modulating miR-196a-5p in bladder cancer
cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N, Gao WJ and Liu NS: LncRNA BCAR4
promotes proliferation, invasion and metastasis of non-small cell
lung cancer cells by affecting epithelial-mesenchymal transition.
Eur Rev Med Pharmacol Sci. 21:2075–2086. 2017.PubMed/NCBI
|
|
14
|
Zou R, Chen X, Jin X, Li S, Ou R, Xue J,
Yan X, Chen L, Hu Y and Zhu H: Up-regulated BCAR4 contributes to
proliferation and migration of cervical cancer cells. Surg Oncol.
27:306–313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang X, Zhu H, Gao Z, Li J, Zhuang J,
Dong Y, Shen B, Li M, Zhou H, Guo H, et al: Wnt7a activates
canonical Wnt signaling, promotes bladder cancer cell invasion, and
is suppressed by miR-370-3p. J Biol Chem. 293:6693–6706. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teng Y, Wang X, Wang Y and Ma D:
Wnt/beta-catenin signaling regulates cancer stem cells in lung
cancer A549 cells. Biochem Biophys Res Commun. 392:373–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
MacLean JA II, King ML, Okuda H and
Hayashi K: WNT7A Regulation by miR-15b in ovarian cancer. PLoS One.
11:e01561092016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Wang X and Jiang X: miR-127
suppresses gastric cancer cell migration and invasion via targeting
Wnt7a. Oncol Lett. 17:3219–3226. 2019.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Wang L, Chunyan Q, Zhou Y, He Q, Ma Y, Ga
Y and Wang X: BCAR4 increase cisplatin resistance and predicted
poor survival in gastric cancer patients. Eur Rev Med Pharmacol
Sci. 21:4064–4070. 2017.PubMed/NCBI
|
|
22
|
Ouyang S, Zheng X, Zhou X, Chen Z, Yang X
and Xie M: LncRNA BCAR4 promotes colon cancer progression via
activating Wnt/β-catenin signaling. Oncotarget. 8:92815–92826.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai Z, Wu Y, Li Y, Ren J and Wang L: BCAR4
activates GLI2 signaling in prostate cancer to contribute to
castration resistance. Aging (Albany NY). 10:3702–3712. 2018.
View Article : Google Scholar
|
|
24
|
Wei L, Yi Z, Guo K and Long X: Long
noncoding RNA BCAR4 promotes glioma cell proliferation via
EGFR/PI3K/AKT signaling pathway. J Cell Physiol. 234:23608–23617.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang H, Yan L, Sun K, Sun X, Zhang X, Cai
K and Song T: lncRNA BCAR4 increases viability, invasion, and
migration of non-small cell lung cancer cells by targeting
glioma-associated oncogene 2 (GLI2). Oncol Res. 27:359–369. 2019.
View Article : Google Scholar
|
|
26
|
Cao MX, Jiang YP, Tang YL and Liang XH:
The crosstalk between lncRNA and microRNA in cancer metastasis:
Orchestrating the epithelial-mesenchymal plasticity. Oncotarget.
8:12472–12483. 2017.
|
|
27
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen JQ, Papp G, Szodoray P and Zeher M:
The role of microRNAs in the pathogenesis of autoimmune diseases.
Autoimmun Rev. 15:1171–1180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lawrie CH: MicroRNAs and haematology:
Small molecules, big function. Br J Haematol. 137:503–512. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ouyang S, Zhou X, Chen Z, Wang M, Zheng X
and Xie M: LncRNA BCAR4, targeting to miR-665/STAT3 signaling,
maintains cancer stem cells stemness and promotes tumorigenicity in
colorectal cancer. Cancer Cell Int. 19:722019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Dou P, Liu T and He S: Application
of long noncoding RNAs in osteosarcoma: Biomarkers and therapeutic
targets. Cell Physiol Biochem. 42:1407–1419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu
H, Ye Z and Li LC: Up-regulation of p21(WAF1/CIP1) by miRNAs and
its implications in bladder cancer cells. FEBS Lett. 588:4654–4664.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang C, Ge Q, Chen Z, Hu J, Li F and Ye Z:
Promoter-associated endogenous and exogenous small RNAs suppress
human bladder cancer cell metastasis by activating p21 (CIP1/WAF1)
expression. Tumour Biol. 37:6589–6598. 2016. View Article : Google Scholar
|
|
36
|
Yamane K, Naito H, Wakabayashi T, Yoshida
H, Muramatsu F, Iba T, Kidoya H and Takakura N: Regulation of SLD5
gene expression by miR-370 during acute growth of cancer cells. Sci
Rep. 6:309412016. View Article : Google Scholar : PubMed/NCBI
|
